bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.06.30.662338

Wolbachia-mediated parthenogenesis induction in the aphid hyperparasitoid Alloxysta brevis (Hymenoptera: Figitidae: Charipinae)

Abstract

Thelytokous parthenogenesis (thelytoky), in which females can produce female offspring without mating, can be caused by parthenogenesis-inducing endosymbiotic bacteria in the genus Wolbachia. This interaction is well known in hymenopteran parasitoids, where unfertilized eggs typically develop as males via haplo-diploidy in the absence of parthenogenesis-inducing bacteria. We report on a case of thelytoky in Alloxysta brevis (Thomson) (Hymenoptera: Figitidae), a globally widespread aphid hyperparasitoid. A previous study had shown that sex ratios of this species collected in Minnesota (USA) were extremely female biased, and we found here that unmated females reared from field-collected hosts produced female offspring without exposure to males. This result demonstrated thelytoky, and we tested for the role of bacterial endosymbionts by comparing offspring production of unmated females fed the antibiotic rifampicin to offspring production of control females not fed antibiotics. Antibiotic-fed females produced almost exclusively male offspring, and control females produced mainly females. This result showed that antibiotic treatment facilitated male production by unmated Alloxysta brevis females, thus implicating bacterial symbiosis in the expression of thelytoky. We then used molecular analyses to determine the identity of the symbiont. These analyses identified a Wolbachia strain from supergroup B, and excluded other bacteria known to mediate parthenogenesis induction, such as Cardinium and Rickettsia. While Wolbachia had been previously detected by molecular analysis in this species, these are the first experiments demonstrating Wolbachia-mediated parthenogenesis in the figitid subfamily Charipinae. IMPORTANCEParthenogenesis induction in insects can have important environmental and economic consequences. This is especially true if pests or their natural enemies are affected. The case of Alloxysta brevis is of particular interest, as this species is a hyperparasitoid of aphids, meaning that they attack and kill primary parasitoids of aphids. The populations of many species of pest aphids are controlled by primary parasitoid species, and hyperparasitoids thus have the potential to interfere with this mechanism of control. The role of hyperparasitoid parthenogenesis in the suppression of aphids by primary parasitoids remains unexplored. Thus, the results of this set of studies provides a starting point for determining whether parthenogenesis-inducing Wolbachia in hyperparasitoids should be expected to improve or hinder biological control of pest aphids by primary parasitoids. The focus on Alloxysta brevis as a model for these questions could be particularly instructive, since it is a species of worldwide distribution that is involved in numerous economically important aphid-parasitoid interactions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Dregni, J., Lindsey, A. R. I., Ferrer-Suay, M., Celis, S., Heimpel, G. E.. 2025-06-30. Wolbachia-mediated parthenogenesis induction in the aphid hyperparasitoid Alloxysta brevis (Hymenoptera: Figitidae: Charipinae). https://doi.org/10.1101/2025.06.30.662338

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗